Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Qualification of Ultrasonography as a Biomarker of Prognosis and Response to Treatment in Early Rheumatoid Arthritis

NCT00781989 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT00781989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00781989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Qualification of Ultrasonography as a Biomarker of Prognosis and Response to Treatment in Early Rheumatoid Arthritis
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Completed
Start date
September 30, 2008
Completion date
April 30, 2011
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis